Safety and Efficacy of Sorafenib in Renal Cell Carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety and Efficacy of Sorafenib in Renal Cell Carcinoma

Published:2012-01 Issue: Volume:5 Page:CGM.S7526
ISSN:1179-0644
Container-title:Cancer Growth and Metastasis
language:en
Short-container-title:Cancer�Growth�Metastasis

Author:

Edeline Julien¹²,Vauléon Elodie¹,Rioux-Leclercq Nathalie³²,Perrin Christophe¹²,Bensalah Cécile Vigneau Karim⁴,Laguerre Brigitte¹

Affiliation:

1. Eugene Marquis Comprehensive Cancer Center, Medical Oncology Department, Rennes, France.

2. CNRS/UMR 6061, IFR140, Rennes1 University, France.

3. CHU Pontchaillou, Pathology Department, Rennes, France.

4. CHU Pontchaillou, Nephrology Department, Rennes, France.

Abstract

This article reviews data on sorafenib use in renal cell carcinoma. Mechanisms of actions and pharmacokinetics are briefly described. Major clinical trials are presented, summarizing efficacy and safety of sorafenib. Its place in current treatment of renal cell carcinoma is discussed. Sorafenib is likely to remain one of the mainstays of RCC treatment in coming years.

Publisher

SAGE Publications

Subject

General Medicine

Link

http://journals.sagepub.com/doi/pdf/10.4137/CGM.S7526

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Angiogenesis in abnormal uterine bleeding: a narrative review;Human Reproduction Update;2023-02-28

2. Clinicopathological and prognostic factors for long-term survival in Chinese patients with metastatic renal cell carcinoma treated with sorafenib: a single-center retrospective study;Oncotarget;2015-10-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP